Ameriprise Financial Inc Axsome Therapeutics, Inc. Transaction History

Ameriprise Financial Inc

$388 Billion
Q2 2025

A detailed history of Ameriprise Financial Inc transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Ameriprise Financial Inc holds 70,084 shares of AXSM stock, worth $8.41 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,084

Previous 16,016 337.59%

Holding current value

$8.41 Million

Previous $1.87 Million 291.86%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$95.65 - $116.49 $5.17 Million - $6.3 Million	54,068 Added 337.59%	70,084 $7.32 Million
Q1 2025 May 14, 2025	SELL	$80.05 - $137.75 $177,871 - $306,080	-2,222 Reduced 12.18%	16,016 $1.87 Million
Q4 2024 Feb 14, 2025	SELL	$83.08 - $100.49 $14.9 Million - $18.1 Million	-179,697 Reduced 90.79%	18,238 $1.54 Million
Q3 2024 Nov 14, 2024	BUY	$78.93 - $95.84 $12 Million - $14.6 Million	152,620 Added 336.8%	197,935 $17.8 Million
Q2 2024 Aug 14, 2024	BUY	$65.72 - $80.5 $2.15 Million - $2.63 Million	32,728 Added 260.01%	45,315 $3.65 Million
Q1 2024 May 15, 2024	BUY	$69.39 - $97.64 $446,732 - $628,606	6,438 Added 104.7%	12,587 $1 Million
Q4 2023 Feb 14, 2024	SELL	$57.42 - $83.61 $1.32 Million - $1.92 Million	-22,993 Reduced 78.9%	6,149 $489,000
Q3 2023 Nov 14, 2023	SELL	$69.25 - $82.21 $35,594 - $42,255	-514 Reduced 1.73%	29,142 $2.04 Million
Q2 2023 Aug 14, 2023	BUY	$58.41 - $90.35 $1.32 Million - $2.04 Million	22,565 Added 318.22%	29,656 $2.13 Million
Q1 2023 May 15, 2023	BUY	$58.39 - $75.0 $68,082 - $87,450	1,166 Added 19.68%	7,091 $437,000
Q4 2022 Feb 14, 2023	BUY	$39.94 - $79.72 $399 - $797	10 Added 0.17%	5,925 $456,000
Q3 2022 Nov 14, 2022	BUY	$36.06 - $69.85 $213,294 - $413,162	5,915 New	5,915 $265,000

Others Institutions Holding AXSM

# of Institutions

403

Shares Held

37.3M

Call Options Held

507K

Put Options Held

540K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $5.14B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Axsome Therapeutics, Inc. Transaction History